Adaptimmune Therapeutics PLC Business Finance Contracts & Agreements

21 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Loan and Security Agreement by and among Adaptimmune Therapeutics PLC, Affiliates, Hercules Capital, Inc., and Lenders (March 24, 2025)
Loan Agreements
Adaptimmune Therapeutics PLC
Biotechnology
CA
2025
Description of Registered Securities of Adaptimmune Therapeutics plc under Section 12 of the Exchange Act
Equity Distribution Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2024
Adaptimmune Therapeutics plc 2015 Share Option Scheme Rules (as Amended)
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Description of Securities Registered Under Section 12 of the Exchange Act – Adaptimmune Therapeutics plc
Equity Distribution Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2023
Description of Ordinary Shares Registered Under Section 12 of the Exchange Act – Adaptimmune Therapeutics plc
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2022
Rent Security Deposit Deed between MEPC Milton Park No. 1 Limited, MEPC Milton Park No. 2 Limited, Adaptimmune Limited, and Adaptimmune Therapeutics plc dated August 20, 2021
Escrow Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2021
Description of Ordinary Shares and American Depositary Shares of Adaptimmune Therapeutics plc Registered Under Section 12 of the Exchange Act
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2021
Description of Ordinary Shares and American Depositary Shares of Adaptimmune Therapeutics plc Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Purchase Agreement for 10,000,000 American Depositary Shares between Adaptimmune Therapeutics plc and Purchasers
Purchase Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2018
Adaptimmune Therapeutics plc 2015 Share Option Scheme Rules (as Amended)
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Rent Security Deposit Deed between MEPC Milton Park No. 1 & 2 Limited and Adaptimmune Limited (39 Innovation Drive)
Escrow Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Purchase Agreement for 7,000,000 American Depositary Shares between Adaptimmune Therapeutics plc and Matrix Capital Management Master Fund, LP (April 5, 2017)
Purchase Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2017
Adaptimmune Therapeutics plc Underwriting Agreement for 14,300,000 American Depositary Shares with Citigroup, Cowen, and Leerink
Underwriting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2017
Amendment Agreement No. 8 to Collaboration and Licence Agreement between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Underwriting Agreement between Adaptimmune Therapeutics plc and Underwriters for Sale of American Depositary Shares (June 1, 2020)
Underwriting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Variation Agreement Amending Supplier Services Agreement Among La Fosse Associates Limited, GAR-1 Business Advisory Services, and Adaptimmune LLC
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Variation Agreement to Client Agreement between La Fosse Associates Limited and Adaptimmune LLC (February 17, 2020)
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Underwriting Agreement between Adaptimmune Therapeutics plc and Cowen and Company, LLC for 21,000,000 American Depositary Shares
Underwriting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Variation Agreement to Service Agreement between Adaptimmune Therapeutics PLC and James Julian Noble (June 26, 2019)
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2019
Amendment Agreement No. 6 to Collaboration and Licence Agreement between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd.
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Amendment Agreement No. 5 to Collaboration and Licence Agreement between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd.
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017